US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks
The US President Donald Trump's proposal to impose tariffs on imported pharmaceutical products has raised concerns in the Indian pharma sector, which is a major supplier of generic drugs to the US market. While the move seems to be largely aimed at …